Search research articles
Contact Us
Filters
Showing results (441-450 of 512) with videos related to
Page
of 52
Sort By:
Neuro-Oncology
|
March 10, 2006
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up
Lauren E Abrey, Barrett H Childs, Nina Paleologos, et al.
Journal of Neuro-Oncology
|
October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02
Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 22, 2026
The EPS-I exopolysaccharide transforms <i>Ralstonia</i> wilt pathogen biofilms into viscoelastic fluids for rapid dissemination in planta
Matthew L Cope-Arguello, Jiayu Li, Zachary Konkel, et al.
Diabetes
|
May 15, 2015
Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance
Qusai Y Al-Share, Anthony M DeAngelis, Sumona Ghosh Lester, et al.
Plos One
|
October 15, 2011
Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology
Gyungah Jun, Michael Nicolaou, Margaux A Morrison, et al.
Neuro-Oncology
|
January 20, 2026
Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)
Lauren R Schaff, Elena Pentsova, Rachna Malani, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2010
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma
Phioanh Leia Nghiemphu, Patrick Y Wen, Kathleen R Lamborn, et al.
Neuro-Oncology
|
February 13, 2010
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas
Jeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.
Neuro-Oncology
|
October 27, 2012
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02
Eudocia Q Lee, John Kuhn, Kathleen R Lamborn, et al.
Blood
|
December 21, 2018
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
Christian Grommes, Sarah S Tang, Julia Wolfe, et al.
Page
of 52
Search research articles
Search
Showing results (441-450 of 512) with videos related to
Sort By:
Page
of 52
Neuro-Oncology
|
March 10, 2006
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up
Lauren E Abrey, Barrett H Childs, Nina Paleologos, et al.
Journal of Neuro-Oncology
|
October 9, 2017
Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02
Phioanh Leia Nghiemphu, Victoria Asuquo Ebiana, Patrick Wen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 22, 2026
The EPS-I exopolysaccharide transforms <i>Ralstonia</i> wilt pathogen biofilms into viscoelastic fluids for rapid dissemination in planta
Matthew L Cope-Arguello, Jiayu Li, Zachary Konkel, et al.
Diabetes
|
May 15, 2015
Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance
Qusai Y Al-Share, Anthony M DeAngelis, Sumona Ghosh Lester, et al.
Plos One
|
October 15, 2011
Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology
Gyungah Jun, Michael Nicolaou, Margaux A Morrison, et al.
Neuro-Oncology
|
January 20, 2026
Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)
Lauren R Schaff, Elena Pentsova, Rachna Malani, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 12, 2010
A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma
Phioanh Leia Nghiemphu, Patrick Y Wen, Kathleen R Lamborn, et al.
Neuro-Oncology
|
February 13, 2010
A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas
Jeffrey J Raizer, Lauren E Abrey, Andrew B Lassman, et al.
Neuro-Oncology
|
October 27, 2012
Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02
Eudocia Q Lee, John Kuhn, Kathleen R Lamborn, et al.
Blood
|
December 21, 2018
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
Christian Grommes, Sarah S Tang, Julia Wolfe, et al.
Page
of 52